과제정보
This study was supported by a National Research Foundation of Korea (NRF) grant funded by the Korean government (No. 2022R1A2C1012697).
참고문헌
- Rubin A, Bellamy J. Practitioner's guide to using research for evidence-based practice. 3rd ed. Wiley; 2022. p. 48-49.
- Sackett DL, Rosenberg WM, Gray JA, Haynes RB, Richardson WS. Evidence based medicine: what it is and what it isn't. British Medical Journal. 1996;312(7023):71-72. https://doi.org/10.1136/bmj.312.7023.71
- Patsopoulos NA, Analatos AA, Ioannidis JP. Relative citation impact of various study designs in the health sciences. Journal of the American Medical Association. 2005;293(19):2362-2366. https://doi.org/10.1001/jama.293.19.2362
- Ioannidis JP. The mass production of redundant, misleading, and conflicted systematic reviews and meta-analyses. The Milbank Quarterly. 2016;94(3):485-514. https://doi.org/10.1111/1468-0009.12210
- Fontelo P, Liu F. A review of recent publication trends from top publishing countries. Systematic Reviews. 2018;7(1):147. https://doi.org/10.1186/s13643-018-0819-1
- Kim G, Baik SK. Overview and recent trends of systematic reviews and meta-analyses in hepatology. Clinical and Molecular Hepatology. 2014;20(2):137-150. https://doi.org/10.3350/cmh.2014.20.2.137
- Grant MJ, Booth A. A typology of reviews: an analysis of 14 review types and associated methodologies. Health Information and Libraries Journal. 2009;26(2):91-108. https://doi.org/10.1111/j.1471-1842.2009.00848.x
- Arksey H, O'Malley L. Scoping studies: towards a methodological framework. International Journal of Social Research Methodology. 2005;8(1):19-32. https://doi.org/10.1080/1364557032000119616
- Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al. Cochrane handbook for systematic reviews of interventions version 6.3 (updated February 2022) [Internet]. Cochrane; 2022 [cited 2023 July 3]. Available from: https://www.training.cochrane.org/handbook
- Granados-Duque V, Garcia-Perdomo HA. Systematic review and meta-analysis: which pitfalls to avoid during this process. International Brazilian Journal of Urology. 2021;47(5):1037-1041. https://doi.org/10.1590/s1677-5538.ibju.2020.0746
- Enhancing the QUAlity and Transparency Of health Research (EQUATOR) Network and UK EQUATOR Centre. EQUATOR Network [Internet]. [cited 2023 July 1]. Available from: https://www.equator-network.org
- Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. PLoS Medicine. 2021;18(3):e1003583. https://doi.org/10.1371/journal.pmed.1003583
- Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Annals of Internal Medicine. 2009;151(4):W65-W94. https://doi.org/10.7326/0003-4819-151-4-200908180-00136
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). PRISMA 2020 Statement [Internet]. 2021 [cited 2023 July 2]. Available from: http://www.prisma-statement.org/PRISMAStatement/PRISMAStatement
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). PRISMA 2020 Checklist [Internet]. 2021 [cited 2023 July 2]. Available from: http://www.prisma-statement.org/PRISMAStatement/Checklist
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). PRISMA 2020 Flow diagram template [Internet]. 2021 [cited 2023 July 2]. Available from: http://www.prisma-statement.org/PRISMAStatement/FlowDiagram
- Cochrane. Cochrane database of systematic reviews [Internet]. [cited 2023 July 2]. Available from: https://www.cochranelibrary.com/cdsr/about-cdsr
- National Institute for Health and Care Research (NIHR). PRO SPERO: International Prospective Register of Systematic Reviews [Internet]. [cited 2023 July 1]. Available from: https://www.crd.york.ac.uk/PROSPERO
- Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. British Medical Journal. 2011;343:d5928. https://doi.org/10.1136/bmj.d5928
- Sterne JAC, Savović J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. British Medical Journal. 2019;366:l4898. https://doi.org/10.1136/bmj.l4898
- Sterne JA, Hernán MA, Reeves BC, Savović J, Berkman ND, Viswanathan M, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. British Medical Journal. 2016;355:i4919. https://doi.org/10.1136/bmj.i4919
- Cochrane. Cochrane methodology. Risk of bias tool for randomized trials (RoB 2) [Internet]. [cited 2023 July 1]. Available from: https://training.cochrane.org/online-learning/cochrane-methodology/risk-bias
- Cochrane. Review Manager 5 (RevMan 5) [Internet]. 2014 [cited 2023 July 1]. Available from: https://community.cochrane.org/help/tools-and-software/revman-5
- Biostat. Comprehensive meta-analysis (CMA) [Internet]. [cited 2023 July 2]. Available from: https://ko.meta-analysis.com/
- Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. Journal of Clinical Epidemiology. 2011;64(4):383-394. https://doi.org/10.1016/j.jclinepi.2010.04.026
- Atkins D, Best D, Briss PA, Eccles M, Falck-Ytter Y, Flottorp S, et al.; GRADE Working Group. Grading quality of evidence and strength of recommendations. British Medical Journal. 2004;328(7454):1490. https://doi.org/10.1136/bmj.328.7454.1490
- GRADEpro GDT: GRADEpro guideline development tool [software]. 2015 [cited 2023 July 1]. Available from: https://gradepro.org
- Shea BJ, Reeves BC, Wells G, Thuku M, Hamel C, Moran J, et al. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. British Medical Journal. 2017;358:j4008. https://doi.org/10.1136/bmj.j4008